Literature DB >> 19075257

Progress in mantle-cell lymphoma.

Peter Martin, Morton Coleman, John P Leonard.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19075257     DOI: 10.1200/JCO.2008.19.5032

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.

Authors:  Zheng Chen; Albert E Teo; Nami McCarty
Journal:  Clin Cancer Res       Date:  2015-09-08       Impact factor: 12.531

2.  Multiple lymphomatous polyposis with diffuse involvement of the gastrointestinal tract. Case report.

Authors:  G Cestaro; M De Rosa; C Vitiello; G Galloro; M Gentile
Journal:  G Chir       Date:  2013 May-Jun

Review 3.  Frontline therapy in mantle cell lymphoma: the role of high-dose therapy and integration of new agents.

Authors:  Brad S Kahl
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

4.  An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.

Authors:  Mauricio Zapata; Steven D Budnick; Rodolfo Bordoni; Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2010-03-20

5.  P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse.

Authors:  Sunil Iyengar; Andrew Clear; Csaba Bödör; Lenushka Maharaj; Abigail Lee; Maria Calaminici; Janet Matthews; Sameena Iqbal; Rebecca Auer; John Gribben; Simon Joel
Journal:  Blood       Date:  2013-01-22       Impact factor: 22.113

6.  Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status.

Authors:  Hesham M Hassan; Michelle L Varney; Nagendra K Chaturvedi; Shantaram S Joshi; Dennis D Weisenburger; Rakesh K Singh; Bhavana J Dave
Journal:  Leuk Lymphoma       Date:  2016-04-13

7.  Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures.

Authors:  Carlos E Caicedo-Carvajal; Qing Liu; Yvonne Remache; Andre Goy; K Stephen Suh
Journal:  J Tissue Eng       Date:  2011-09-05       Impact factor: 7.813

8.  Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?

Authors:  Sebastian Kirschey; Susanne Wagner; Georg Hess
Journal:  Clin Med Insights Oncol       Date:  2012-03-12

9.  Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth.

Authors:  Fu-Lian Qu; Bing Xia; Su-Xia Li; Chen Tian; Hong-Liang Yang; Qian Li; Ya-Fei Wang; Yong Yu; Yi-Zhuo Zhang
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

Review 10.  Current trials for frontline therapy of mantle cell lymphoma.

Authors:  Raphael E Steiner; Jorge Romaguera; Michael Wang
Journal:  J Hematol Oncol       Date:  2018-01-27       Impact factor: 17.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.